|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Breastcancer.org: U.S. Breast Cancer
Statistics: http://www.breastcancer.org/symptoms/understand_bc/statistics.jsp
(accessed December 21, 2011).
|
|
3.
|
Ali SM, Harvey HA and Lipton A: Metastatic
breast cancer: overview of treatment. Clin Orthop. 414(Suppl):
132–137. 2003. View Article : Google Scholar
|
|
4.
|
Fidler IJ: Molecular biology of cancer:
invasion and metastasis. Cancer: Principles and Practice of
Oncology. De Vita VT, Hellman S and Rosenberg SA: 5th edition.
Lippincott-Raven; Philadelphia, PA: pp. 135–152. 1997
|
|
5.
|
Rath M and Pauling L: Plasmin-induced
proteolysis and the role of apoprotein(a), lysine and synthetic
analogs. Orthomol Med. 7:17–23. 1992.
|
|
6.
|
Nunez MC, De Apodaca O and Ruiz AL:
Ascorbic acid in the plasma and blood cells of women with breast
cancer. The effect of consumption of food with an elevated content
of this vitamin. Nutr Hosp. 10:368–372. 1995.PubMed/NCBI
|
|
7.
|
Anthony HM and Schorah CJ: Severe
hypovitaminosis C in lung-cancer patients: the utilization of
vitamin C in surgical repair and lymphocyte-related host
resistance. Br J Cancer. 46:354–367. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Pulaski BA and Ostrand-Rosenberg S: Mouse
4T1 breast tumor model. Curr Protoc Immunol Chapter. 20:Unit
20.2.2001. View Article : Google Scholar
|
|
9.
|
Tao K, Fang M, Alroy J and Sahagian GG:
Imagable 4T1 model for the study of late stage breast cancer. BMC
Cancer. 8:2282008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Hart IR and Fidler IJ: Role of organ
selectivity in the determination of metastatic patterns of B16
melanoma. Cancer Res. 40:2281–2297. 1980.PubMed/NCBI
|
|
11.
|
Mayland CR, Bennett MI and Allan K:
Vitamin C deficiency in cancer patients. Palliat Med. 19:17–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kuiper C, Molenaar IG, Dachs GU, Currie
MJ, Sykes PH and Vissers MC: Low ascorbate levels are associated
with increased hypoxia-inducible factor-1 activity and an
aggressive tumor phenotype in endometrial cancer. Cancer Res.
70:5749–5758. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Cameron E, Pauling L and Leibovitz B:
Ascorbic acid and cancer: a review. Cancer Res. 39:663–681.
1979.
|
|
14.
|
Stetler-Stevenson WG, Hewitt R and
Corcoran M: Matrix metalloproteinases and tumor invasion from
correlation and causality to the clinic. Semin Cancer Biol.
7:147–154. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Bachmeier BE, Nerlich AG, Lichtinghagen R
and Sommerhoff CP: Matrix metalloproteinases (MMPs) in breast
cancer cell lines of different tumorigenicity. Anticancer Res.
6A:3821–3828. 2001.PubMed/NCBI
|
|
16.
|
Pellikainen JM, Ropponen KM, Kataja VV,
Kellokoski JK, Eskelinen MJ and Kosma VM: Expression of matrix
metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special
reference to activator protein-2, HER-2, and prognosis. Clin Cancer
Res. 10:7621–7628. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Nikkola J, Vihinen P, Vuorista MS,
Kellokumpu-Lehtinen P, Kähäri VM and Pyrhönen S: High serum levels
of matrix metalloproteinase-9 and matrix metallopreoteinase-1 are
associated with rapid progression in patients with metastatic
melanoma. Clin Cancer Res. 11:5158–5166. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Bonfil RD, Bustuabad OD, Ruggiero RA,
Meiss RP and Pasqualini CD: Tumor necrosis can facilitate the
appearance of metastases. Clin Exp Metastasis. 6:121–129. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Bonfil RD, Medina PA, Gómez DE, Farías E,
Lazarowski A, Lucero Gritti MF, Meiss RP and Bustuabad OD:
Expression of gelatinase/type IV collagenase in tumor necrosis
correlates with cell detachment and tumor invasion. Clin Exp
Metastasis. 10:211–220. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Argilés JM, Busquets S, Toledo M and
López-Soriano FJ: The role of cytokines in cancer cachexia. Curr
Opin Support Palliat Care. 3:263–268. 2009.
|
|
21.
|
Deans C and Wigmore SJ: Systemic
inflammation, cachexia and prognosis in patients with cancer. Curr
Opin Clin Nutr Metab Care. 8:265–269. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Musselman D, Miller A, Porter M, Manatunga
A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS and
Nemeroff CB: Higher than normal plasma interleukin-6 concentrations
in cancer patients with depression: Preliminary findings. Am J
Psychiatry. 158:1252–1257. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Bower J, Ganz P, Desmond K, Rowland J,
Meyerowitz BE and Belin TR: Fatigue in breast cancer survivors:
occurrence, correlates and impact on quality of life. J Clin Oncol.
18:743–753. 2000.PubMed/NCBI
|
|
24.
|
Lyon DE, McCain NL, Walter J and Schubert
C: Cytokine comparisons between women with breast cancer and women
with a negative breast biopsy. Nurs Res. 57:51–58. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Yurkovetsy ZR, Kirkwood JM, Edington HD,
Marragoni AM, Velikokhatnaya L, Winans MT, Gorelik E and Lokshin
AE: Multiplex analysis of serum cytokines in melanoma patients
treated with interferon-α2b. Clin Cancer Res. 13:2422–2428.
2007.
|
|
26.
|
Lazar-Molnar E, Hegyesi H, Toth S and
Falus A: Autocrine and paracrine regulation by cytokines and growth
factors in melanoma. Cytokine. 12:547–554. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Leek R and Harris A: Tumor-associated
macrophages in breast cancer. J Mammary Gland Biol Neoplasia.
7:177–189. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Bachelot T, Ray-Coquard I, Menetrier-Caux
C, Rashtkha M, Duc A and Blay JY: Prognostic value of serum levels
of interleukin 6 and of serum and plasma levels of vascular
endothelial growth factor in hormone-refractory metastatic breast
cancer patients. Br J Cancer. 88:1721–1726. 2003. View Article : Google Scholar
|
|
29.
|
Salgado R, Junius S, Benoy I, Van Dam P,
Vermeulen P, Van Marck E, Huget P and Dirix LY: Circulating
interleukin-6 predicts survival in patients with metastatic breast
cancer. Int J Cancer. 103:642–646. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Zhang GJ and Adachi I: Serum interleukin-6
levels correlate to tumor progression and prognosis in metastatic
breast carcinoma. Anticancer Res. 19:1427–1432. 1999.PubMed/NCBI
|
|
31.
|
Mouawad R, Benhammouda A, Rixe O, Antoine
EC, Borel C, Weil M, Khayat D and Soubrane C: Endogenous
interleukin 6 levels in patients with metastatic malignant
melanoma: correlation with tumor burden. Clin Cancer Res.
2:1405–1409. 1996.PubMed/NCBI
|
|
32.
|
Mouawad R, Rixe O, Meric JB, Khayat D and
Soubrane C: Serum interleukin 6 concentration as predictive factor
of time to progression in metastatic malignant melanoma patients
treated by biochemotherapy: a retrospective study. Cytokines Cell
Mol Ther. 7:151–156. 2002. View Article : Google Scholar
|
|
33.
|
Tawara K, Oxford JT and Jorcyk CL:
Clinical significance of interleukin (IL)-6 in cancer metastasis to
bone: potential of anti-IL-6 therapies. Cancer Manag Res.
3:177–189. 2011.PubMed/NCBI
|
|
34.
|
Maeda N, Hagihara H, Nakata Y, Hiller S,
Wilder J and Reddick R: Aortic wall damage in mice unable to
synthesize ascorbic acid. Proc Natl Acad Sci USA. 97:841–846. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Harakeh S, Diab-Assaf M, Khalife JC,
Abu-El-Ardat KA, Baydoun E, Niedzwiecki A, Marwan E, El-Sabban ME
and Rath M: Ascorbic acid induces apoptosis in adult T-cell
leukemia. Anticancer Res. 27:289–298. 2007.PubMed/NCBI
|
|
36.
|
Gravenkamp C, Sypniewska R, Gauntt S,
Tarango M, Price P and Reddick R: Behavior of metastatic and
nonmetastatic breast tumors in old mice. Exp Biol Med. 229:665–675.
2004.PubMed/NCBI
|
|
37.
|
Cha J, Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Ascorbate depletion increases growth and
metastasis of melanoma cells in vitamin C deficient mice. Exp
Oncol. 33:226–230. 2011.PubMed/NCBI
|
|
38.
|
McCormick WJ: Cancer: a collagen disease,
secondary to nutritional deficiency? Arch Pediatr. 76:166–171.
1959.PubMed/NCBI
|
|
39.
|
Ichim TE, Minev B, Braciak T, Luna B,
Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ,
Miranda-Massari JR, Alexandrescu DT, Dasunu CA, Bogin V, Ancans J,
Stvens RB, Markosian B, Koropatnick J, Chen CS and Riordan NH:
Intravenous ascorbic acid to prevent and treat cancer-associated
sepsis? J Transl Med. 9:25–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
